.gif){kind=small}
July 25, 2013
Abstract Submission Now Open for the SITC 2013 Workshop on Personalized Cancer Immunotherapy!
New this year, SITC is accepting abstracts for the 2013 Workshop on Personalized Cancer Immunotherapy and SITC invites members and non-members alike to submit abstracts! Up to three submitted abstracts will be selected for oral presentations and all accepted Workshop abstracts will be published in the Workshop syllabus, available on-site the day of the program, Thursday, November 7, 2013.
Workshop Abstract Submission Categories:
- New Sequencing Technology/Validation of Mutation Data/Bioinformatics
- Genomic Instability and Mutations in Different Cancers
- What to do with a T cell Epitope Once You Have It
- Matching Individual Patients to Optimal Immunotherapy
Workshop Abstract Criteria
- Fall under one of the four submission categories listed above
- Discuss the problems and issues in the specified category and include potential solutions
- Have a primary emphasis on exciting new data
- Consist of approximately 200 words not including title, authors or institutions.
Other Important Information:
- Workshop abstract submission is FREE for both members and non-members alike
- Workshop abstract submission will close on August 26, 2013 at 11:59 pm PST
- Authors of accepted abstracts will be notified via email during the week of September 9, 2013
- Early registration rates for the Workshop on Personalized Cancer Immunotherapy and other SITC 2013 programs are available for a limited time at: www.sitcancer.org/2013/registration
Workshop Description:
Cancer cells contain mutations and other alterations that make them recognizable by the immune system. Recent technological advances in genomics, proteomics and immunophenotyping now allow personalized identification of these alterations for targeting with therapeutics, including immunotherapy. However, many questions remain: What are the best bioinformatics approaches to accurately mining individual tumor samples? How do you use this data to define the most promising therapeutic targets/strategies? How do you integrate genomic information with immunophenotypic data to personalize immunotherapies for cancer patients?
The purpose of this Workshop is to bring participants up to date on the latest in patient-specific genomic and molecular analysis, and the application of this information in personalized immunotherapy of cancer. Technologies include genome-wide DNA and RNA sequencing, epigenetic regulation and transcript variation, identification of mutations, polymorphisms associated with cancer risk and clinical outcome, patient-specific T cell epitope discovery, and immunophenotyping. Applications include choosing the “right” antigen, induction of therapeutic immunity, blocking of immune checkpoints such as CTLA-4 and PD-1, combinations of immunotherapy with targeted therapy, and patient-specific immune monitoring. By participating in the Workshop, participants will interact with international leaders in the field of personalized immunotherapy to learn about the latest technologies, current applications, critical unaddressed questions, and future directions. Most importantly, participants will have the opportunity to build connections and collaborations to spark new discoveries, interventions and applications.
Workshop Organizers:
Willem W. Overwijk, PhD - MD Anderson Cancer Center
Hans-Georg Rammensee, PhD - Universitaet Tuebingen
Nicholas P. Restifo, MD - National Cancer Institute
Ena Wang, MD - National Institutes of Health, CC, DTM
For more information on the SITC Workshop and abstract submission, visit: www.sitcancer.org/2013/workshop.
